Family Medicine · Lawrence, MA
NPI
1295794204
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
25 Marston St, Suite 304
Lawrence, MA, 01841
Phone (978) 688-3100
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
1,122 services
Medicare patients, 2024
176
Average age 67
Drug cost, 2024
$648K
7,552 prescriptions
Company payments, 2025
$341
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Asia Zaheen was code 99214 (office e&m - established), 442 times for 150 patients. In total Asia Zaheen billed 1,122 services in 29 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-03-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 442 | 150 | $95.66 | $42K |
| 93000 Electrocardiogram | Office | 97 | 84 | $10.42 | $1,010 |
| 99213 Office E&M - Established | Office | 93 | 68 | $64.62 | $6,009 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 80 | 80 | $134.91 | $11K |
| G0008 Administration of influenza virus vaccine | Office | 33 | 32 | $32.81 | $1,083 |
| 87400 Immunoassay | Office | 26 | 12 | $13.85 | $360 |
| 90653 Vaccine Product | Office | 22 | 22 | $81.82 | $1,800 |
| 81002 Clinical Chemistry | Office | 17 | 14 | $3.41 | $57.97 |
| 87636 Infectious Agent Detection by DNA/RNA | Office | 16 | 15 | $139.78 | $2,236 |
By year: 2022 $97K for 1,662 services; 2023 $70K for 1,213 services; 2024 $76K for 1,122 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87400 Immunoassay | 26 | 12 | $13.85 | $360 |
| 81002 Clinical Chemistry | 17 | 14 | $3.41 | $57.97 |
| 87636 Infectious Agent Detection by DNA/RNA | 16 | 15 | $139.78 | $2,236 |
Medicare prescription drug claims, 2024
In 2024, the drug Asia Zaheen prescribed most often to Medicare patients was Atorvastatin Calcium, with 351 prescriptions and refills. In total Asia Zaheen wrote 7,552 Medicare prescriptions that cost $648K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 351 | 886 | 108 | $4,059 |
| Amlodipine Besylate Generic | 336 | 859 | 103 | $2,203 |
| Levothyroxine Sodium Generic | 245 | 558 | 55 | $2,606 |
| Omeprazole Generic | 222 | 567 | 87 | $4,405 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 215 | 275 | 60 | $6,236 |
| Metformin Hcl Generic | 197 | 477 | 53 | $1,969 |
| Gabapentin Generic | 191 | 288 | 52 | $2,635 |
| Pantoprazole Sodium Generic | 187 | 469 | 69 | $4,387 |
| Lisinopril Generic | 176 | 477 | 54 | $1,215 |
| Simvastatin Generic | 169 | 401 | 44 | $1,227 |
| Losartan Potassium Generic | 159 | 440 | 51 | $1,779 |
| Azithromycin Generic | 149 | 149 | 111 | $518 |
| Furosemide Generic | 136 | 291 | 42 | $781 |
| Alprazolam Generic | 130 | 144 | 24 | $1,004 |
| Metoprolol Succinate Generic | 127 | 285 | 34 | $1,913 |
Brand drugs: 949 claims; generic drugs: 6,556 claims; opioid claims: 249.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Asia Zaheen $341 ($341 in general payments such as food, travel and fees) from 12 companies. The largest payer was Pfizer Inc. with $48.83.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 2 | $48.83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40.88 |
| GlaxoSmithKline, LLC. GSK | 1 | $30.05 |
| Heartflow, Inc. HTFL | 1 | $27.89 |
| Lilly USA, LLC LLY | 1 | $27.56 |
| Novo Nordisk Inc NVO | 1 | $26.76 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $25.63 |
| Hologic Sales and Service, LLC HOLX | 1 | $24.46 |
| Exact Sciences Corporation EXAS | 1 | $23.96 |
| Sumitomo Pharma America, Inc. 4506.T | 1 | $23.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.